Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP was delisted on the 5th of October, 2023.
1 hedge funds and large institutions have $116 invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
97% less capital invested
Capital invested by funds: $3.95K → $116 (-$3.83K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIS
Strategic Investment Solutions
Orland Park,
Illinois
|
-$3.83K |
HZNP Hedge Fund Activity: Q3 2024 in Review
1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q3 2024, worth a combined $116 — down 97% from $3.95K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HZNP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Strategic Investment Solutions, exiting entirely with an estimated $3.83K sold.
- 1 institutional investor held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q3 2024, down from 2 in Q2 2024.
- Funds reported $116 of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q3 2024, down 97% quarter-over-quarter.
- 0 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q3 2024 was Strategic Investment Solutions, an estimated $3.83K sold.
Based on aggregated 13F filings for Q3 2024.